Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Barry A. Browne, PharmD

Articles by Barry A. Browne, PharmD

Evaluation of Dual Versus Triple Therapy for Hepatitis C

ByNicol D. Brown, PharmD, MSCR,Barry A. Browne, PharmD,Christine Kim, PharmD,Chanhee Jo, PhD,Dawn Sears, MD

December 16th 2014

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.

Latest Updated Articles

Evaluation of Dual Versus Triple Therapy for Hepatitis C
Published: December 16th 2014 | Updated:

Trending on Pharmacy Times

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

Breaking News: CVS Buys Rite Aid, Bartell Drugs

FDA Approves 1-Minute HIV Self-Test

Young Women With Symptomatic Long COVID At Higher Risk of POTS

Kellermensch: Living With the Emotional Weight of a Career in Health Care

© 2025 MJH Life Sciences^®

All rights reserved.